Tina Ventura | Senior Vice President of Investor Relations |
Timothy Walbert | Chairman, President and Chief Executive Officer |
Paul Hoelscher | Executive Vice President and Chief Financial Officer |
Shao-Lee Lin | Executive Vice President, Head of Research and Development and Chief Scientific Officer |
Robert Carey | Executive Vice President and Chief Business Officer |
Vikram Karnani | Executive Vice President and Chief Commercial Officer |
Dana Flanders | Goldman Sachs & Co. LLC |
David Amsellem | Piper Jaffray & Co., |
Annabel Samimy | Stifel, Nicolaus & Company, Inc. |
David Steinberg | Jefferies LLC |
Kenneth Cacciatore | Cowen and Company, LLC |
Louise Chen | Cantor Fitzgerald LP |
Donald Ellis | JMP Securities LLC |
David Risinger | Morgan Stanley & Co. LLC. |
Gary Nachman | BMO Capital Markets Corp. |
Irina Koffler | Mizuho Securities USA Inc. |
Good morning, and thank you for standing by. Welcome to the Horizon Pharma Fourth Quarter and Full-Year 2018 Earnings Conference Call.
As a reminder, today's conference call is being recorded. I would now like to introduce Ms. Tina Ventura, Senior Vice President of Investor Relations.